SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biolase, Inc – ‘10-K’ for 12/31/18

On:  Friday, 3/8/19, at 12:33pm ET   ·   For:  12/31/18   ·   Accession #:  1564590-19-6918   ·   File #:  1-36385

Previous ‘10-K’:  ‘10-K’ on 3/14/18 for 12/31/17   ·   Next:  ‘10-K’ on 3/30/20 for 12/31/19   ·   Latest:  ‘10-K’ on 3/21/24 for 12/31/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/08/19  Biolase, Inc                      10-K       12/31/18   86:14M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.28M 
 2: EX-10.28    Material Contract                                   HTML     93K 
 3: EX-21.1     Subsidiaries List                                   HTML     22K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     26K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
15: R1          Document and Entity Information                     HTML     60K 
16: R2          Consolidated Balance Sheets                         HTML    109K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
18: R4          Consolidated Statements Of Operations And           HTML    108K 
                Comprehensive Loss                                               
19: R5          Consolidated Statements Of Shareholders' Equity     HTML     95K 
20: R6          Consolidated Statements Of Shareholders' Equity     HTML     26K 
                (Parenthetical)                                                  
21: R7          Consolidated Statements Of Cash Flows               HTML    141K 
22: R8          Basis of Presentation                               HTML     43K 
23: R9          Summary of Significant Accounting Policies          HTML    277K 
24: R10         Supplementary Balance Sheet Information             HTML    138K 
25: R11         Intangible Assets and Goodwill                      HTML     66K 
26: R12         Income Taxes                                        HTML    226K 
27: R13         Debt                                                HTML     91K 
28: R14         Commitments and Contingencies                       HTML     47K 
29: R15         Stockholders' Equity                                HTML    418K 
30: R16         Segment Information                                 HTML     49K 
31: R17         Concentrations                                      HTML     89K 
32: R18         Subsequent Events (Unaudited)                       HTML     31K 
33: R19         Schedule II-Consolidated Valuation and Qualifying   HTML    118K 
                Accounts and Reserves                                            
34: R20         Summary of Significant Accounting Policies          HTML    367K 
                (Policies)                                                       
35: R21         Summary of Significant Accounting Policies          HTML    242K 
                (Tables)                                                         
36: R22         Supplementary Balance Sheet Information (Tables)    HTML    144K 
37: R23         Intangible Assets and Goodwill (Tables)             HTML     64K 
38: R24         Income Taxes (Tables)                               HTML    224K 
39: R25         Debt (Tables)                                       HTML     78K 
40: R26         Commitments and Contingencies (Tables)              HTML     36K 
41: R27         Stockholders' Equity (Tables)                       HTML    353K 
42: R28         Segment Information (Tables)                        HTML     47K 
43: R29         Concentrations (Tables)                             HTML     89K 
44: R30         Basis of Presentation - Additional Information      HTML     68K 
                (Detail)                                                         
45: R31         Summary of Significant Accounting Policies -        HTML    100K 
                Additional Information (Detail)                                  
46: R32         Schedule of Reconciliation of Cash, Cash            HTML     36K 
                Equivalents, and Restricted Cash (Detail)                        
47: R33         Estimated Useful Lives of Property, Plant and       HTML     38K 
                Equipment (Detail)                                               
48: R34         Summary of Opening and Closing Balances of          HTML     40K 
                Contract Liabilities (Detail)                                    
49: R35         Summary of Disaggregation of Revenues Related to    HTML     32K 
                Geographic Areas (Detail)                                        
50: R36         Summary of Revenues Disaggregated by Timing of      HTML     33K 
                Goods and Services Transferred (Detail)                          
51: R37         Summary of Sales by End Market (Detail)             HTML     33K 
52: R38         Changes in Initial Product Warranty Accrual and     HTML     40K 
                Expenses Under Initial and Extended Warranties                   
                (Detail)                                                         
53: R39         Classification of Compensation Expense Associated   HTML     38K 
                with Share-Based Payments (Detail)                               
54: R40         Assumptions Used in Estimating Fair Value of Stock  HTML     33K 
                Options Granted (Detail)                                         
55: R41         Components of Accounts Receivable, Net of           HTML     33K 
                Allowance (Detail)                                               
56: R42         Supplementary Balance Sheet Information -           HTML     42K 
                Additional Information (Detail)                                  
57: R43         Components of Inventory (Detail)                    HTML     35K 
58: R44         Summary of Property, Plant, and Equipment (Detail)  HTML     50K 
59: R45         Components of Accrued Liabilities (Detail)          HTML     49K 
60: R46         Intangible Assets and Goodwill - Additional         HTML     33K 
                Information (Detail)                                             
61: R47         Intangible Assets and Related Accumulated           HTML     52K 
                Amortization (Detail)                                            
62: R48         Summary of Income Tax Current and Deferred          HTML     43K 
                Provision (Detail)                                               
63: R49         Federal Income Tax Provision Compared With          HTML     55K 
                Statutory Rates (Detail)                                         
64: R50         Summary of Net Deferred Tax Assets and Net          HTML     78K 
                Deferred Tax Liabilities (Detail)                                
65: R51         Income Taxes - Additional Information (Detail)      HTML     80K 
66: R52         Summary of Unrecognized Tax Benefits (Detail)       HTML     31K 
67: R53         Debt - Summary of Principal Outstanding and         HTML     32K 
                Unamortized Discount (Detail)                                    
68: R54         Debt - Additional Information (Detail)              HTML    161K 
69: R55         Debt - Summary of Future Minimum Principal          HTML     51K 
                Payments (Detail)                                                
70: R56         Commitments and Contingencies - Additional          HTML     48K 
                Information (Detail)                                             
71: R57         Future Minimum Rental Commitments Under Lease       HTML     35K 
                Agreements (Detail)                                              
72: R58         Stockholders' Equity - Additional Information       HTML    810K 
                (Detail)                                                         
73: R59         Summary of Warrant Activity (Detail)                HTML     54K 
74: R60         Summary of Option Activity (Detail)                 HTML     66K 
75: R61         Options Outstanding and Exercisable (Detail)        HTML     66K 
76: R62         Cash Proceeds Along with Fair Value Disclosures     HTML     36K 
                Related to Grants, Exercises, and Vesting Options                
                (Detail)                                                         
77: R63         Summary of Unvested Restricted Stock Units          HTML     37K 
                (Detail)                                                         
78: R64         Segment Information - Additional Information        HTML     38K 
                (Detail)                                                         
79: R65         Summary of Long-Lived Assets by Geographic          HTML     33K 
                Location (Detail)                                                
80: R66         Concentrations - Summary of Net Revenue from        HTML     52K 
                Various Products (Detail)                                        
81: R67         Concentrations - Additional Information (Detail)    HTML     33K 
82: R68         Subsequent Events (unaudited) - Additional          HTML     63K 
                Information (Detail)                                             
83: R69         Consolidated Valuation and Qualifying Accounts and  HTML     39K 
                Reserves (Detail)                                                
85: XML         IDEA XML File -- Filing Summary                      XML    152K 
84: EXCEL       IDEA Workbook of Financial Reports                  XLSX    114K 
 9: EX-101.INS  XBRL Instance -- biol-20181231                       XML   4.07M 
11: EX-101.CAL  XBRL Calculations -- biol-20181231_cal               XML    226K 
12: EX-101.DEF  XBRL Definitions -- biol-20181231_def                XML    707K 
13: EX-101.LAB  XBRL Labels -- biol-20181231_lab                     XML   1.72M 
14: EX-101.PRE  XBRL Presentations -- biol-20181231_pre              XML   1.23M 
10: EX-101.SCH  XBRL Schema -- biol-20181231                         XSD    257K 
86: ZIP         XBRL Zipped Folder -- 0001564590-19-006918-xbrl      Zip    248K 




        
Filing Submission 0001564590-19-006918 – SGML Text

Original SGML Text submitted by:  ActiveDisclosure/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 2:20:58.2pm ET